See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Alejandro Godoy

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	41183346	0	Godoy A, Douketis JD. In cancer-associated thrombosis, DOACs reduce VTE and increase clinically relevant nonmajor bleeding vs. LMWH at 3 to 12 mo. Ann Intern Med. 2025 Nov 4. doi: 10.7326/ANNALS-25-04088-JC.
	39581233	0	Carlin S, Chan N, Godoy A, et al. Choosing the optimal oral anticoagulant for stroke prevention in atrial fibrillation: direct oral anticoagulants vs vitamin K antagonists. J Thromb Haemost. 2024 Nov 23:S1538-7836(24)00695-0. doi: 10.1016/j.jtha.2024.11.005.
	39307620	0	Godoy A, Galli NB, Tabares A. Psychological aspects in young people with venous thromboembolic disease, preliminary report. Hematol Transfus Cell Ther. 2024 Nov;46 Suppl 5(Suppl 5):S233-S238. doi: 10.1016/j.htct.2024.06.007. Epub 2024 Sep 8.
	38889799	0	Hirsh J, Godoy A, Chan NC. Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference? Semin Thromb Hemost. 2024 Jun 18. doi: 10.1055/s-0044-1787726.
	38296660	0	Godoy A, Carlin S, Douketis JD. Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time? Eur J Intern Med. 2024 Apr;122:40-41. doi: 10.1016/j.ejim.2024.01.032. Epub 2024 Jan 30.
	38176536	0	Godoy A, Chan NC, Bhagirath V, et al. FRAIL-AF Study: More Bleeding With DOACs Compared With VKAs in Patients With Frailty? Can J Cardiol. 2024 Aug;40(8):1377-1378. doi: 10.1016/j.cjca.2023.12.030. Epub 2024 Jan 2.